The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1248 Weight Loss articles
Started GLP-1s for weight loss or blood sugar control but seeing no results? New research in Genome Medicine reveals that 10% of people carry PAM gene variants linked to weaker responses. Experts explain genetics, common pitfalls, testing, and effective alternatives to help you succeed.
Christina Aguilera turned heads at the Breakthrough Prize Ceremony, appearing 'thinner than ever' in a plunging black leather dress that highlighted her minuscule waist. Amid ongoing Ozempic rumors, fans commented 'Ozempic strikes again' on her super-slim frame. This sighting reignites discussions on celebrity weight loss and GLP-1 medications.
Country music sensation Luke Combs is turning down GLP-1 medications for weight loss, opting for the hard road instead. In a candid New York Times interview, he shares fears about his appearance affecting his career and why 'that stuff scares me more than the benefits.' This stance highlights debates around quick fixes versus lifelong habits in weight management.
A groundbreaking study in Nature Health sifted through 410,198 Reddit posts mentioning semaglutide or tirzepatide, revealing hidden side effects like reproductive issues and temperature fluctuations that go beyond typical nausea. While 43.5% of users reported symptoms, experts like Dr. Jeffrey Lee stress the need for clinical confirmation. This guide explores these findings and what they mean for patients.
Amazon is entering the GLP-1 weight loss market with a new program through One Medical and Amazon Pharmacy, promising fast, convenient access to treatments like Wegovy and Zepbound. With pricing as low as $25/month for insured patients and same-day delivery, it positions weight management as a chronic care solution. This could transform how patients access these popular medications.
A generic version of Ozempic semaglutide has received tentative USFDA approval, marking a key step toward affordable GLP-1 therapy. Orbicular spearheaded product development, partnering with OneSource Specialty Pharma as the CDMO for reliable U.S. market manufacturing. This collaboration promises steady commercial supply from an FDA-approved site.
Thirty million Americans—one in eight—are turning to GLP-1 drugs like Ozempic for weight management and more, with data showing a 20% reduced risk of heart attacks and strokes. But what happens when the weight doesn't budge, as in 10% of users? This personal story explores the hype, realities, and broader implications of these medications.
A gynaecologist at Aston University has won a £60,000 NHS research grant to probe the potential of weight-loss drugs like Ozempic and Mounjaro in treating polycystic ovary syndrome (PCOS). This initiative aims to evaluate their impact on metabolic health and fertility in affected women. Discover the project's details and why it matters for patient care.
Love Island star Shaughna Phillips is celebrating a 9kg weight loss over four months, sharing transparent before-and-after videos despite cellulite and lipoedema flare-ups. Rejecting Ozempic claims, she credits gym sessions, protein-focused eating, and her Shred It Plan. Her journey emphasizes progress over perfection for busy moms.
